DOP76: Corticosteroid sparing effects of ustekinumab therapy for Ulcerative Colitis through 2 years: UNIFI long-term extensionECCO'20 Vienna 2020
DOP78: Intestinal surgery rates in Ulcerative Colitis and Crohn’s Disease in the era of biologics – A Danish Nationwide Register Study from 2003-2016ECCO'20 Vienna 2020
DOP79: Dose escalation of upadacitinib in Crohn’s Disease patients with inadequate response: Data from the randomised CELEST studyECCO'20 Vienna 2020
DOP80: Effectiveness of ustekinumab and vedolizumab in patients with Crohn’s Disease refractory to anti-tumor necrosis factor: A multi-center comparative studyECCO'20 Vienna 2020
DOP82: Macrophages in Crohn’s Disease mesentery are predominantly inflammatory and produce calprotectinECCO'20 Vienna 2020
DOP84: Crohn’s Disease modifies the DNA methylome of human adipose-stem cells, which is only partially re-established in remissionECCO'20 Vienna 2020